Dormiva Anti-Snoring Mouth Guard
Device Facts
| Record ID | K261134 |
|---|---|
| Device Name | Dormiva Anti-Snoring Mouth Guard |
| Applicant | Koncept Innovators, Inc. |
| Product Code | LRK · Dental |
| Decision Date | May 14, 2026 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 872.5570 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Indications for Use
Dormiva Anti-Snoring Mouth Guard is an over-the-counter mouth guard intended for use in adult persons 18 years of age or older as an aid for the reduction of snoring.
Device Story
Dormiva Anti-Snoring Mouth Guard; self-fitting, adjustable mandibular advancement device (MAD); used for reduction of nighttime snoring. Device consists of two pre-fabricated, single-piece trays (thermoplastic resin/TPE/polycarbonate) and a spatula. User performs 'boil and bite' method to customize fit to dentition; device worn in situ during sleep to move lower jaw forward; increases pharyngeal space; improves air exchange. Used at home by adult patients. Output is physical repositioning of mandible; affects clinical decision-making by providing non-surgical snoring relief. Available in three sizes (small, medium, large).
Clinical Evidence
No clinical data provided. Substantial equivalence based on non-clinical bench testing, including hardness, water sorption, solubility, flexural strength, flexural modulus, fracture toughness, and optical microscopy. Biocompatibility testing included in vitro cytotoxicity (ISO 10993-5), skin sensitization (ISO 10993-10), and oral mucosal irritation (ISO 10993-10).
Technological Characteristics
Mandibular advancement device; materials: Ethylene-Vinyl-Acetate (moldable) and Polycarbonate (rigid); spatula/case: Polypropylene. Manufacturing: injection molding. Dimensions: three sizes (S, M, L). Connectivity: none. Sterilization: non-sterile. Biocompatibility: ISO 10993-1 compliant. Functional testing: ISO 20795-2.
Indications for Use
Indicated for adult persons 18 years of age or older as an aid for the reduction of snoring. Not indicated for obstructive sleep apnea.
Regulatory Classification
Identification
Intraoral devices for snoring and intraoral devices for snoring and obstructive sleep apnea are devices that are worn during sleep to reduce the incidence of snoring and to treat obstructive sleep apnea. The devices are designed to increase the patency of the airway and to decrease air turbulence and airway obstruction. The classification includes palatal lifting devices, tongue retaining devices, and mandibular repositioning devices.
Special Controls
*Classification.* Class II (special controls). The special control for these devices is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA.”
Predicate Devices
- SOMNOS ANTI-SNORING MOUTH GUARD (K201484)
Submission Summary (Full Text)
{0}
FDA U.S. FOOD & DRUG ADMINISTRATION
May 14, 2026
Koncept Innovators, Inc.
% Maureen Garner
Regulatory Consultant
Newworld Regulatory Solutions, Inc.
11700 W. Charleston Blvd. Suite 170-390
Las Vegas, Nevada 89135
Re: K261134
Trade/Device Name: Dormiva Anti-Snoring Mouth Guard
Regulation Number: 21 CFR 872.5570
Regulation Name: Intraoral Devices For Snoring And Intraoral Devices For Snoring And Obstructive Sleep Apnea
Regulatory Class: Class II
Product Code: LRK, LQZ
Dated: April 6, 2026
Received: April 7, 2026
Dear Maureen Garner:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
U.S. Food & Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993
www.fda.gov
{1}
K261134 - Maureen Garner
Page 2
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality Management System Regulation (QMSR) (21 CFR Part 820), which includes, but is not limited to, ISO 13485 clause 7.3 (Design controls), ISO 13485 clause 8.3 (Nonconforming product), ISO 13485 clause 8.5.2 (Corrective action), and ISO 13485 clause 8.5.3 (Preventative action). Please note that regardless of whether a change requires premarket review, the QMSR requires device manufacturers to review and approve changes to device design and production (ISO 13485 clause 7.3 and ISO 13485 clause 7.5) and document changes and approvals in the Medical Device File (ISO 13485 clause 4.2.3).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reporting-combination-products); good manufacturing practice requirements as set forth in the Quality Management System Regulation (QMSR) (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the
{2}
K261134 - Maureen Garner
Page 3
Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
MICHAEL E. ADJODHA -S
Michael E. Adjodha, MChE, RAC, CQIA
Assistant Director
DHT1B: Division of Dental and ENT Devices
OHT1: Office of Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices
Office of Product Evaluation and Quality
Center for Devices and Radiological Health
Enclosure
{3}
| Indications for Use | | |
| --- | --- | --- |
| Please type in the marketing application/submission number, if it is known. This textbox will be left blank for original applications/submissions. | K261134 | ? |
| Please provide the device trade name(s). | | ? |
| Dormiva Anti-Snoring Mouth Guard | | |
| Please provide your Indications for Use below. | | ? |
| DORMIVA ANTI-SNORING MOUTH GUARD is an over-the-counter mouth guard intended for use in adult persons 18 years of age or older as an aid for the reduction of snoring. | | |
| Please select the types of uses (select one or both, as applicable). | [ ] Prescription Use (21 CFR 801 Subpart D) [X] Over-The-Counter Use (21 CFR 801 Subpart C) | ? |
{4}
Koncept Innovators, LLC.
Dormiva Anti-Snoring Mouth Guard
Special 510(k)
# General Summary of Submission/Executive Summary K261134
## Submission Sponsor
Koncept Innovators, LLC.
1619 Executive Ave
Myrtle Beach, SC 29577
Contact: Sylvan Newby
Title: President
Phone: 843-945-4031
Email: sylvan@Sylvancompany.com
## Submission Correspondent
New World Regulatory Solutions, Inc.
11700 W. Charleston Blvd
Suite 170-390
Las Vegas, NV 89135
Contact: Maureen Garner
Title: President
Phone: 732-779-7422
Email: NWRSinc@gmail.com
## Date Prepared
January 31, 2026
## Type of 510(k) Submission
Special(k)
## Device Identification
| Trade /Proprietary Name: | Dormiva Anti-Snoring Mouth Guard |
| --- | --- |
| Common Name: | Device, Anti-snoring |
| Classification: | II |
| FDA Product Code: | LRK |
| Review Panel: | Dental |
## Legally Marketed Predicate Device
## Primary Predicate Device:
SOMNOS ANTI-SNORING MOUTH GUARD, K201484
This legally marketed device predicate has not been subject to a design-related recall.
{5}
Koncept Innovators, LLC.
Dormiva Anti-Snoring Mouth Guard
Special 510(k)
# Device Description
Dormiva Anti-Snoring Mouth Guard is comprised of a mouth guard, a spatula and a storage case. The mouth guard is a self-fitting adjustable Mandibular Advancement Device (MAD) removable intraoral anti-snoring device used to reduce nighttime snoring in adult persons 18 years of age or older. The Dormiva Anti-Snoring Mouth Guard consists of two customized pre-fabricated single-piece trays that conform to the person's dentition in the upper and lower jaws. The device functions as a mandibular anterior repositioner, which acts to increase the user's pharyngeal space, resulting in the improvement of the ability to exchange air during sleep. Dormiva Anti-Snoring Mouth Guard, while in situ, moves the lower jaw forward and helps reduce the likelihood of snoring. It is intended to be worn while sleeping. The spatula supplied is used to separate the Dormiva Anti-Snoring Mouth Guard. Dormiva Anti-Snoring Mouth Guard is comfortable to wear, and it can be self-fitted by the 'boil and bite' method (when heated the device conforms to a person's teeth) and allows slight adjustment of the anterior positioning of the jaw to the person's comfort.
Dormiva Anti-Snoring Mouth Guard is constructed of two (2) preformed and fixed single piece trays composed of Thermoplastic resin Propylene Elastomer (TPE) material, specifically Ethylene-Vinyl-Acetate for the moldable part and Polycarbonate for the rigid part of the device. The spatula and storage case are composed of 100% Polypropylene. The materials in Dormiva Anti-Snoring Mouth Guard are the same materials used in the SOMNOS ANTI-SNORING MOUTH GUARD cleared under K201484 and are commonly used in other 510(k)-cleared dental mouth guards for bruxism and anti-snoring. The three components (mouth guard, spatula and storage case) are manufactured by injection molding. They are non-flavored and have no color additives.
Dormiva Anti-Snoring Mouth Guard is provided in three (3) models/sizes (small, medium and large), is reusable by a single person who is at least eighteen (18) years of age and is supplied as non-sterile. Each box of a Dormiva Anti-Snoring Mouth Guard is supplied with the following items:
- (1) Anti-snoring Mouth Guard
- (1) Spatula
- (1) Storage case
- (1) Instructions for Use
# Indications for Use
Dormiva Anti-Snoring Mouth Guard is an over-the-counter mouth guard intended for use in adult persons 18 years of age or older as an aid for the reduction of snoring.
# Summary of Substantial Equivalence
Dormiva Anti-Snoring Mouth Guard, like the primary predicate (SOMNOS ANTI-SNORING MOUTH GUARD, K201484), is an intraoral anti-snoring mouth guard device that functions as a mandibular anterior repositioner, which acts to increase the user's pharyngeal space, resulting in the improvement of the ability to exchange air during sleep. Both devices, while in situ, move the lower jaw forward and help reduce the likelihood of snoring
The intended indications, and directions for use of the Dormiva Anti-Snoring Mouth Guard are equivalent to those of the predicate device, SOMNOS ANTI SNORING MOUTH GUARD. The
{6}
Koncept Innovators, LLC.
Dormiva Anti-Snoring Mouth Guard
Special 510(k)
materials, manufacturing, and principle of operation are the same as those of the predicate device and do not raise any new issues concerning safety or effectiveness.
## COMPARISON TO THE PREDICATE
The purpose of this Special 510(k) submission is to bring to market the device under the proprietary name, Dormiva Anti-Snoring Mouth Guard, now available in three sizes. There have been no changes made to the composition or materials of the device; the only difference is that the mouth guard has been reduced in thickness and is available in small, medium and large. (See table below for specifications.)
## Summary of Technological Characteristics
The table below compares the technological characteristics of the Dormiva Anti-Snoring Mouth Guard and the primary predicate, SOMNOS ANTI-SNORE MOUTH GUARD.
Comparison of Technological Characteristics of Subject and Predicate Devices
| | Subject Device | Predicate Device | Similarities |
| --- | --- | --- | --- |
| Trade Name / Brand Name | Dormiva Anti-Snoring Mouth Guard | SOMNOS ANTI-SNORING MOUTH GUARD | N/A |
| 510(k)# | TBD | K201484 | N/A |
| Indications for Use | Dormiva Anti-Snoring Mouth Guard is an over-the-counter mouth guard intended for use in adult persons 18 years of age or older as an aid for the reduction of snoring. | SOMNOS ANTI-SNORING GUARD is an over-the-counter mouth guard intended for use in adult persons 18 years of age or older as an aid for the reduction of snoring. | Same |
| Device Description | Mandibular repositioning device that advances the lower jaw to increase pharyngeal space. Adjustment of the relative position of the trays by the use of latch adjustment to obtain a fixed advancement. | Mandibular repositioning device that advances the lower jaw to increase pharyngeal space. Adjustment of the relative position of the trays by the use of latch adjustment to obtain a fixed advancement. | Same |
| Patient Population | Adult persons 18 years of age or older | Adult persons 18 years of age or older | Same |
| Duration of Use | Single person, multi-use | Single person, multi-use | Same |
| Desirable Characteristics | Home use, heat sensitive/moldable position [Boil and Bite Method (Heat & Bite Self-Fit)], adjustable jaw advancement | Home use, heat sensitive/moldable position [Boil and Bite Method (Heat & Bite Self-Fit)], adjustable jaw advancement | Same |
| Rx or OTC | OTC | OTC | Same |
| Specifications -Mechanical | -Repositions mandible-anteriorly up to 6 mm | -Repositions mandible-anteriorly up to 6 mm | Same |
| Method of Manufacturing | Injection Molding | Injection Molding | Same |
| Biocompatibility | Biocompatible Materials Used -- | Biocompatible Materials Used -- | Same |
{7}
Koncept Innovators, LLC.
Dormiva Anti-Snoring Mouth Guard
Special 510(k)
| | Subject Device | Predicate Device | Similarities |
| --- | --- | --- | --- |
| | ISO 10993 | ISO 10993 | |
| Specifications -Physical -Use | -Custom-fitted intraoral device -Reusable | Custom-fitted intraoral device -Reusable | Same |
| Sterility | Non-Sterile | Non-Sterile | Same |
| Materials | -Ethylene Vinyl Acetate copolymer -Polycarbonate resin No Flavor; No Color Additives | -Ethylene Vinyl Acetate copolymer -Polycarbonate resin No Flavor; No Color Additives | Same |
| Tray Design | Pre-formed and fixed | Pre-formed and fixed | Same |
| Accessories Provided | “Spatula” for handling devices during molding steps | “Spatula” for handling devices during molding steps | Same |
| Total allowed molding attempts | 3 | 4 | Same |
| Replacement recommended | 6 months | 6 months | Same |
Differences Between Subject and Predicate Devices
| | Subject Device | Predicate Device |
| --- | --- | --- |
| Trade Name / Brand Name | Dormiva Anti-Snoring Mouth Guard | Somnos Anti-Snoring Mouth Guard |
| Models/Sizes Available | Three sizes available: small, medium, large | One size available |
| Dimensions | Small • Height 25.5 mm • Depth 37.0 mm • Inner width 21.8 mm • Outer Width 54.7 mm Medium • Height 25.5 mm • Depth 39.0 mm • Inner width 26 mm • Outer Width 58.7 mm Large • Height 25.5 mm • Depth 42.9 mm • Inner width 29.8 mm • Outer Width 63 mm Spatula • Length 47.5 mm • Width 11.0 mm (17 mm flare at base) • Thickness 2.25 mm | One Size • Height 27.7 mm • Depth 42.6 mm • Inner width 32.1 mm • Outer Width 67.6 mm Spatula • Length 73.0 mm • Width 14.30 mm to 22.3 mm Thickness 1.60 mm |
{8}
Koncept Innovators, LLC.
Dormiva Anti-Snoring Mouth Guard
Special 510(k)
| | Subject Device | Predicate Device |
| --- | --- | --- |
| Trade Name / Brand Name | Dormiva Anti-Snoring Mouth Guard | Somnos Anti-Snoring Mouth Guard |
| | | |
In accordance with section 513(i)(1)(A) of the FDCA, a device is substantially equivalent when it has the same intended use and same or similar technological characteristics as a legally marketed predicate device. As demonstrated in this Special 510(k), there are no differences between the subject device and the cited predicate other than introduction of three new sizes with varied dimensions/thickness. It is on this basis that the Dormiva Anti-Snoring Mouth Guard is substantially equivalent to the cited predicate device.
## Summary of Performance Data
There were no clinical tests performed or provided in this submission.
The same functional performance tests conducted on the Somnos Anti-Snoring Mouth Guard in accordance with FDA Recognized Consensus Standard, ISO 20795-2 Dentistry – Base polymers – Part 2: Orthodontic base polymers apply to the Dormiva Anti-Snoring Mouth Guard. They are as follows:
- Hardness, Water Sorption and Solubility Testing;
- Spatula & Mouth guard Boiling/Cooling Water Testing;
- Flexural Strength & Flexural Modulus;
- Fracture Toughness; and
- Optical Microscopy (OM).
A biocompatibility assessment was conducted using Somnos Anti-Snoring Mouth Guard as a final finished device in accordance with International Standard ISO 10993-1:2009 Biological evaluation of medical devices – Part 1 Evaluation and testing within a risk management process and FDA’s Guidance Document, Use of International Standard ISO 10993-1, “Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process,” June 16, 2016. This biocompatibility assessment is the same for the Dormiva Anti-Snoring Mouth Guard device.
The following biocompatibility performance tests were conducted on Somnos Anti-Snoring Mouth Guard and apply to the Dormiva Anti-Snoring Guard:
- In Vitro Cytotoxicity Test using ISO 10993-5:2009 Test Method - MTT Method MEM with 10%FBS extract
- Skin Sensitization Test using ISO 10993-10:2010 Test Method – Guinea Pig Maximization Test 0.9% Sodium Chloride Injection Extract
- Skin Sensitization Test using ISO 10993-10:2010 Test Method – Guinea Pig Maximization Test Sesame Oil Extract
- Oral Mucosal Irritation Test using ISO 10993-10:2010 Test Method – Hamster 0.9% Sodium Chloride Extract
- Oral Mucosal Irritation Test using ISO 10993-10:2010 Test Method – Hamster Sesame Oil Extract
{9}
Koncept Innovators, LLC.
Dormiva Anti-Snoring Mouth Guard
Special 510(k)
Koncept Innovators conducted a risk analysis on DORMIVA ANTI-SNORING MOUTH GUARD in accordance with ISO 14971, taking into account the issues raised in the FDA Guidance Document, "Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea -Guidance for Industry and FDA." With respect to perceivable conditions in which the device would be subjected to a worst-case environmental of human error scenario, Koncept Innovators believes the outcomes of these risks are considered acceptable within the context of ISO 14971, and that all potential risks have been mitigated to the lowest form. The identified potential risks have been addressed through device design or with communication with the user through the instructions for use. Dormiva Anti-Snoring Mouth Guard uses a STOP BANG questionnaire on the labeling to assess the risks of sleep apnea and contains appropriate warnings and labeling for the device to be used without a prescription. Dormiva Anti-Snoring Mouth Guard is not indicated for obstructive sleep apnea.
Dormiva Anti-Snoring Mouth Guard relied on biocompatibility and functional performance testing as the basis for non-clinical data. The non-clinical testing performed is the same as that used to demonstrate substantial equivalence of the SOMNOS ANTI-SNORING MOUTH GUARD.
## Statement of Substantial Equivalence
The Dormiva Anti-Snoring Mouth Guard has the same intended use and indications for use as the predicate, SOMNOS ANTI-SNORING MOUTH GUARD. All technological features of the subject device when compared to the predicate device are the same and have been successfully evaluated through safety and performance testing and other verification and validation activities such that the information submitted to the FDA demonstrates that the subject device, when compared to the predicate device, does not raise any new questions of safety and effectiveness. Dormiva Anti-Snoring Mouth Guard, as designed by and manufactured for Koncept Innovators, LLC. has been determined to be substantially equivalent to the predicate device, SOMNOS ANTI-SNORING MOUTH GUARD. The Dormiva Anti-Snoring Mouth Guard is available in three (3) sizes, and the mouth guard thickness has been reduced. All labeling has been updated.
